Publications by authors named "M Zawada"

Article Synopsis
  • * A 3-year study, TRANSLATE NAMSE, analyzed data from 1,577 patients, revealing that 32% received molecular diagnoses involving 370 distinct causes, primarily uncommon.
  • * The research showed that combining next-generation sequencing with advanced phenotyping methods improved diagnostic efficiency and helped identify new genotype-phenotype associations, particularly in neurodevelopmental disorders.
View Article and Find Full Text PDF
Article Synopsis
  • Treatment-free remission (TFR) is achievable in about 50% of CML patients on tyrosine kinase inhibitors, but the mechanisms for maintaining TFR are not well understood.
  • This study analyzed immune markers in 63 CML patients who had stopped imatinib, finding that an increase in CD8PD-1 cells correlates with a higher chance of losing TFR.
  • Results indicate that the level of CD8PD-1 cells could help predict early molecular recurrence, particularly highlighting differences between patients with different e13a2 and e14a2 transcripts.
View Article and Find Full Text PDF

We report on laser cooling of a large fraction of positronium (Ps) in free flight by strongly saturating the 1^{3}S-2^{3}P transition with a broadband, long-pulsed 243 nm alexandrite laser. The ground state Ps cloud is produced in a magnetic and electric field-free environment. We observe two different laser-induced effects.

View Article and Find Full Text PDF

Metallopeptidases are a group of metal-dependent enzymes that hydrolyze peptide bonds. These enzymes found in Streptococcus pneumoniae assist the pathogen in infecting the host by breaking down host tissues and extracellular matrix proteins. Considering metallopeptidases' significant role in bacterial virulence, inhibiting this enzyme represents a promising avenue for research.

View Article and Find Full Text PDF

Adult acute lymphoblastic leukemia (ALL) is associated with poor outcomes. ALL is initiated by primary aberrations, but secondary genetic lesions are necessary for overt ALL. In this study, we reassessed the value of primary and secondary aberrations in intensively treated ALL patients in relation to mutator enzyme expression.

View Article and Find Full Text PDF